NCT05116267 Assessment of the Effectiveness and Safety Outcome in Patients With Atrial Fibrillation Treated by Apixaban in Belgium Status WITHDRAWN Phase N/A
NCT05116046 Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondroplasia Status TERMINATED Phase PHASE2
NCT05107492 Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy Participants Status COMPLETED Phase PHASE1
NCT05099471 Efficacy of Venetoclax in Combination With Rituximab in Waldenström's Macroglobulinemia Status RECRUITING Phase PHASE2
NCT05097716 Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide Status COMPLETED Phase PHASE1
NCT05097599 StrataPATH™ (Precision Indications for Approved Therapies) Status TERMINATED Phase PHASE2
NCT05096208 Clinical Lot Consistency for RSVpreF in a Population of Healthy Adults 18 to ≤49 Years of Age Status COMPLETED Phase PHASE3
NCT05093205 STUDY TO EVALUATE THE EFFECT OF PF-06882961 ON SINGLE DOSE ATORVASTATIN, MEDAZOLAM AND ORALCONTRACEPTIVE PHARMACOKINETICS IN HEALTHY ADULT PARTICIPANTS Status COMPLETED Phase PHASE1
NCT05090566 MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma Status TERMINATED Phase PHASE2
NCT05082428 This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data. Status COMPLETED Phase N/A
NCT05081440 A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center Status UNKNOWN Phase N/A
NCT05071937 ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer Status RECRUITING Phase PHASE2
NCT05070845 Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05069259 Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes. Status TERMINATED Phase N/A
NCT05067972 A Study of PF-07260437 in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1